India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The AIIMS will start the booster dose trial of Bharat Biotech’s intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at … Read more
New Delhi: The technology innovation hubs of IIT Delhi (iHub foundation) and IIIT Delhi (iHub Anubhuti) will collaborate to develop India’s first Medical Cobotics Centre (MCC) at IIIT-Delhi. The hubs, funded by the Department of Science and Technology (DST), will develop training programs in consultation with leading doctors and healthcare experts. The planned Medical Cobotics … Read more
(This story originally appeared in on Jul 25, 2020) NEW DELHI: Delhi government and National Centre for Disease Control have planned to conduct a sample survey among people who recently underwent the serological survey in the capital. The step is being taken to find out the prevalence of Covid-19 antibodies and its sustainability in people … Read more